Pharmacological group and classification
Omeprazole (Omeprazolum) belongs to agents affecting digestive system functions. It is a reference drug from the group of antisecretory agents—medicines that suppress hydrochloric acid secretion by parietal cells of the stomach. Within this group, it represents the class of proton pump inhibitors ($H^+/K^+$-ATPase inhibitors). To understand the drug's position: antisecretory agents also include $H_2$-histamine receptor blockers (cimetidine, famotidine) and muscarinic antagonists (atropine, pirenzepine).
Mechanism of action and pharmacodynamics
By chemical structure, the drug is a benzimidazole derivative. Its mechanism of action consists of the irreversible blockade of the $H^+/K^+$-ATPase enzyme (proton pump) on the membrane of gastric lining (parietal) cells.
The drug exhibits exceptionally high efficacy: just a single oral dose suppresses gastric secretion by more than 90% for 24 hours. Unlike antacids (such as algeldrate, magnesium carbonate, or sodium bicarbonate), which merely provide brief (30–60 minutes) chemical neutralization of acid already present in the gastric lumen, omeprazole blocks the very process of its formation.
Indications for use
The main indication is an exacerbation of peptic ulcer disease.
The drug is also a crucial agent for the prevention and management of NSAID-induced gastropathy. The administration of nonsteroidal anti-inflammatory drugs causes non-receptor inhibition of the COX-1 enzyme, which reduces the synthesis of protective prostaglandins ($PgE_2$, $PgI_2$) in the gastric wall. An imbalance between aggressive and protective factors arises: acid secretion increases against the background of decreased mucus and bicarbonate production. This leads to mucosal ulceration and a high risk of gastrointestinal bleeding. The administration of omeprazole (gastroprotection) effectively prevents this damage. It is important to remember that attempting to wash down NSAIDs with milk is largely ineffective: milk only temporarily buffers the acid, but does not eliminate the systemic suppression of prostaglandin synthesis.
Side Effects and Risks of Long-Term Therapy
Dyspepsia ( nausea) and headache may occur during treatment.
The main limitations are associated with the duration of therapy. The treatment course for an ulcer exacerbation should not exceed 4–8 weeks. The reason lies in the «rebound» mechanism: prolonged achlorhydria (absence of acid) triggers an increase in gastrin secretion via a feedback loop. This leads to hyperplasia of enterochromaffin-like and parietal cells (found in 10–20% of patients) and increases the risk of gastric mucosal atrophy.
Drug Interactions (Cytochrome P450)
Omeprazole actively affects the cytochrome P450 system, acting both as a substrate and as an inducer/inhibitor of various isoenzymes:
- CYP1A2: Omeprazole is a pharmacological inducer of this isoenzyme (along with phenobarbital and rifampicin). This can accelerate the metabolism of substrates (caffeine, theophylline, paracetamol, warfarin). A dangerous risk of CYP1A2 and CYP1A1 induction is bioactivation of carcinogens: certain environmental substances become carcinogenic only after metabolic activation.
- CYP2C19: The drug is a substrate and simultaneously an inhibitor (auto-inhibition) of this isoenzyme. This harbors a dangerous paradoxical effect when co-administered with prodrugs (prodrugs). For instance, the antiplatelet agent clopidogrel requires activation via CYP2C19. Omeprazole blocks this enzyme, reducing the concentration of clopidogrel's active metabolite, which leads to a decrease in antithrombotic efficacy and a high risk of thrombosis.
- CYP2D6: Omeprazole acts as a substrate for this isoenzyme (along with codeine, haloperidol, and metoprolol).
Administration guidelines and prescription
The drug is prescribed orally, in the morning before meals. The standard dose is 0.02 g (20 mg) once daily. An important rule: the capsule must be swallowed whole, without damaging it (do not open or chew).
Example of a prescription: Rp.: Caps. Omeprazoli 0.02 D.t.d. N. 20 S. Take orally in the morning before meals, 1 capsule once daily (do not damage the capsule).
Briefly: answers to topical questions
What are the indications for use of omeprazole?
Omeprazole is used for the treatment of acid-related gastrointestinal diseases. The main indications are gastroesophageal reflux disease, peptic ulcer disease, Zollinger–Ellison syndrome, and symptomatic ulcers. In addition, the drug is part of standardized eradication regimens upon the detection of Helicobacter pylori, and is also used for the prevention and management of NSAID-induced gastropathies during concurrent administration with nonsteroidal anti-inflammatory drugs.
What side effects can occur during omeprazole therapy?
Dyspeptic disorders, including nausea, as well as headache, may occur during omeprazole therapy. Potential risks of long-term therapy include activation of the cytochrome P450 system, which can cause drug interactions, and an increased risk of developing gastric mucosal atrophy. Furthermore, hyperplasia of enterochromaffin-like and parietal cells may develop as a result of achlorhydria and increased gastrin secretion.
OMEPRAZOLE: Abolishes Metabolism (of clopidogrel), Suppresses (the pump), Rebounds (with gastrin upon prolonged use).
Class and exam questions
Why should omeprazole not be used long-term in peptic ulcer disease?
Prolonged achlorhydria triggers a «rebound» mechanism: compensatory elevation of gastrin levels occurs, leading to hyperplasia of enterochromaffin-like and parietal cells, and also increasing the risk of gastric mucosal atrophy.
How does omeprazole affect the efficacy of clopidogrel?
Omeprazole inhibits the CYP2C19 isoenzyme, which is necessary for converting the inactive prodrug clopidogrel into its active metabolite. This critically reduces the antithrombotic effect and increases the risk of thrombosis.
Does milk help prevent NSAID-induced gastropathy instead of omeprazole?
No. Milk only temporarily buffers the acid, but does not eliminate the systemic inhibition of COX-1 and the deficiency of protective prostaglandins. Omeprazole serves as an effective pharmacological prophylaxis in this situation.
What else to study on this topic
- Physiology of Hydrochloric Acid Secretion and the Role of $H^+/K^+$-ATPase
- Pathogenesis of NSAID-Induced Gastropathy: The Role of COX-1 and Protective Prostaglandins
- Cytochrome P450 System: Clinical Significance of Inducers and Inhibitors
- Prodrugs in Pharmacology and Mechanisms of Their Bioactivation
- Comparative Characteristics of Proton Pump Inhibitors and $H_2$-Histamine Blockers
Master the entire topic in the «Pharmacology» course
This is a summary. The course covers everything tested in classes and exams.
- Complete Study Guide on «Omeprazole» and 5,304 Other Subject Pages
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 116 video lessons on the subject
Other topics in the «Drugs and Prescriptions» section
Free video lessons: pharmacologyShort lessons with study notes — no registration required.
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.